Russell C. Petter
Corporate Officer/Principal presso Avila Therapeutics, Inc.
Profilo
Russell C.
Petter is the founder of Arrakis Therapeutics, Inc. founded in 2015, where he held the title of Chief Scientific Officer.
He is currently the Vice President-Drug Discovery at Avila Therapeutics, Inc. Dr. Petter's former positions include Principal at Biogen MA, Inc. and Biogen, Inc., Vice President-Research at Mersana Therapeutics, Inc., and Principal at Sandoz Research Institute.
Dr. Petter received his undergraduate degree from Dartmouth College in 1978 and his doctorate from Duke University in 1993.
Posizioni attive di Russell C. Petter
| Società | Posizione | Inizio |
|---|---|---|
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Corporate Officer/Principal | 16/04/2009 |
Precedenti posizioni note di Russell C. Petter
| Società | Posizione | Fine |
|---|---|---|
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Fondatore | - |
| Sandoz Research Institute | Corporate Officer/Principal | - |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| MERSANA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Russell C. Petter
| Dartmouth College | Undergraduate Degree |
| Duke University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
| Sandoz Research Institute | |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Russell C. Petter
